Progesterone as an immunomodulatory molecule

International Immunopharmacology

Volumn 1, Issue 6, 2001, Pages 1037-1048

  Szekeres Bartho, Julia ^a   Barakonyi, A ^a   Par, G ^a   Polgar, B ^a   Palkovics, T ^a   Szereday, L ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; FETAL ANTIGEN; PHOSPHOLIPASE A2; PROGESTERONE; PROGESTERONE INDUCED BLOCKING PROTEIN; PROGESTERONE RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

BINDING SITE; ENZYME ACTIVITY; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; HORMONE SENSITIVITY; HUMAN; IMMUNE RESPONSE; LIPID METABOLISM; LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; FEMALE; HUMANS; PREGNANCY; PREGNANCY PROTEINS; PROGESTERONE;

EID: 0035030936     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00035-2     Document Type: Review

References (115)

1. Ferre F., Uzan M., Jolivet A., Jassens Y., Tanguy G., Sureau C.et al. Influence of the oral administration of micronized progesterone on plasma and tissue steroid levels in human pregnancy. Acta Physiol. Hung. 65:1985;44-48.
2. Philibert D., Moguilewsky M., Mary I., Lecaque D., Tournemine C., Secchi J.et al. Pharmacological profile of RU 486 in animals. Baulieu E.E., Segal J.S. The Antiprogestin Steroid RU 486 and Human Fertility Control. 1985;49 Plenum, New York.
3. Puri C.P., Kholkute S.D., Pongubala J.M.R., Patil R.K., Elger W.A.G., Jayaraman S. Effect of the antiprogestin ZK.98734 on the ovarian cycle, early pregnancy and on its binding to progesterone receptors in the myometrium of marmoset Callithrix jacchus. Biol. Reprod. 38:1988;528-534.
4. Tchernitchin X., Tchernitchin A., Galand P. Dynamics of eosinophils in the uterus after oestrogen administration. Differentiation. 5:1976;151-154.
5. Wira C.R., Sandoe C.P. Hormonal regulation of immunoglobulins: influence of estradiol in immunoglobulins A and G in the rat uterus. Endocrinology. 106:1980;1020-1026.
6. Moriyama I., Sugawa T. Progesterone facilitates implantation of xenogeneic cultured cells in hamster uterus. Nat. New Biol. 236:1972;150-152.
7. Mori T., Kobayashi H., Nashimoto H., Suzuki A., Nishimura T. Inhibitory effect of progesterone and 20-alpha hydroxypregn-4-n-3-one on the phytohaemagglutinin-induced transformation of human lymphocytes. Am. J. Obstet. Gynecol. 127:1977;151-157.
8. Pavia C., Siiteri P.K., Perlman J.D., Stites D.P. Suppression of murine allogeneic cell interactions by sex hormones. J. Reprod. Immunol. 1:1979;33-38.
9. Wyle F.A., Kent J.R. Immunosuppression by sex steroid hormones: I. The effect upon PHA and PPD stimulated lymphocytes. Clin. Exp. Immunol. 27:1977;407-415.
10. Szekeres-Bartho J., Hadnagy J., Pacsa A.S. The suppressive effect of progesterone on lymphocyte cytotoxicity: unique progesterone sensitivity of pregnancy lymphocytes. J. Reprod. Immunol. 7:1985;121-128.
11. 2+ signaling, and gene expression in T lymphocytes. J. Exp. Med. 188:1998;1593-1602.
12. Loosfelt H., Logeat F., Vu Hai M.T., Milgrom E. The rabbit progesterone receptor. Evidence for a single steroid binding sub-unit and characterization of receptor mRNA. J. Biol. Chem. 259:1984;14196-14202.
13. Szekeres-Bartho J., Reznikoff-Etievant M.F., Varga P., Varga Z., Chaouat G. Lymphocytic progesterone receptors in human pregnancy. J. Reprod. Immunol. 16:1989;239-247.
14. Szekeres-Bartho J., Szekeres G.Y., Debre P., Autran B., Chaouat G. Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell. Immunol. 125:1990;273-283.
15. Szekeres-Bartho J., Philibert D., Chaouat G. Progesterone suppression of pregnancy lymphocytes is not mediated by a gluccorticoid effect. Am. J. Reprod. Immunol. 23:1990;42-43.
16. Kimoto Y. A single human cell expresses all messenger ribonucleic acids: the arrow of time in a cell. Mol. Gen. Genet. 258:1998;233-239.
17. Daniel L., Vincent C., Rousset F., Klein B., Bataille R., Flacher M.et al. Estrogen and progesterone receptors in semen human myeloma cell lines and murine hybridomas. J. Steroid Biochem. 30:1988;363-367.
18. Pasanen S., Ylikomi T., Palojoki E., Syvala H., Pelto-Huikko M., Tuohimaa P. Progesterone receptor in chicken bursa of Fabricius and thymus: evidence for expression in B-lymphocytes. Mol. Cell. Endocrinol. 141:1998;119-128.
19. Chiu L., Nishimure M., Ishii Y., Nieda M., Maeshima M., Takedani Y.et al. Enhancement of the expression of progesterone receptor on progesterone-treated lymphocytes after immunotherapy in unexplained spontaneous abortion. Am. J. Reprod. Immunol. 35:1996;552-557.
20. King A., Gardner L., Loke Y.W. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum. Reprod. 11:1996;1079-1082.
21. Steward J.A., Bulmer J.N., Murdoch A.P. Endometrial leucocytes: expression of steroid hormone receptors. J. Clin. Pathol. 51:1998;121-126.
22. Jones R.K., Bulmer J.N., Searle R.F. Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Hum. Reprod. Update. 4:1998;702-709. Review.
23. van den Heuvel M., McBey B.-A., Hahnel A.C., Croy B.A. An analysis of the uterine lymphocyte-derived hybridoma cell line GWM 1-2 for expression of receptors for estrogen, progesterone and interleukin 2. J. Reprod. Immunol. 31:1996;37-50.
24. Roussev R.G., Higgins N.G., McIntyre A. Phenotypic characterization of normal human placental mononuclear cells. J. Reprod. Immunol. 25:1993;15-29.
25. Defletsen M.A., Smith B.C., Dickerman H.W. A high affinity low-capacity receptor for estradiol in normal and anaemic mouse spleen cytosols. Biochem. Biophys. Res. Commun. 76:1977;1151-1158.
26. Screpanti I., Gulino A., Pasqualini J.R. The fetal thymus of guinea pig as an estrogen target organ. Endocrinology. 111:1982;1552-1561.
27. Cohen J.H.M., Danel L., Cordier G., Saez S., Revillard J.P. Sex steroid receptors in peripheral T cells: absence of androgen receptor and restriction of estrogen receptors to OKT8 positive cells. J. Immunol. 131:1983;2767-2771.
28. Stimson W.H. Oestrogen and human T lymphocytes: presence of specific receptors in the T suppressor cytotoxic subset. Scand. J. Immunol. 28:1988;345-350.
29. Paldi A., d'Auriol L., Misrahi M., Bakos A.M., Chaouat G., Szekeres-Bartho J. Expression of the gene coding for the progesterone receptor in activated human lymphocytes. Endocr. J. 2:1994;317-321.
30. Szekeres-Bartho J., Weill B.J., Mike G., Houssin D., Chaouat G. Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol. Lett. 22:1989;259-261.
31. Billington W.D. The nature and possible functions of MHC antigens on the surface of human trophoblast. Gupta S.K. Reproductive Immunology. 1999;Narosa Publishing House, New Delhi, India.
32. Weintraub B.C., Jackson M.R., Hedrick S.M. γ/δ T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J. Immunol. 153:1994;3051-3058.
33. Born W., Hall L., Dallas A.et al. Recognition of a peptide antigen by heat shock-reactive γ/δ T lymphocytes. Science. 240:1990;67-69.
34. Polgar B., Barakonyi A., Xynos I., Szekeres-Bartho J. The role of γ/δ TCR positive cells in pregnancy. Am. J. Reprod. Immunol. 41:1999;239-244.
35. Szekeres-Bartho J., Barakonyi A., Polgar B., Par G., Faust Zs., Palkovics T.et al. The role of γ/δ T cells in progesterone-mediated immunomodulation during pregnancy. Am. J. Reprod. Immunol. 42:1999;44-48.
36. Barakonyi A., Polgar B., Szekeres-Bartho J. The role of γ/δ TCR positive cells in pregnancy II. Am. J. Reprod. Immunol. 42:1999;83-87.
37. Mincheva Nilsson L., Baranov V., Yeung M., Mo-Way, Hammarstrom S., Hammarstrom M.-L. Immunomorphologic studies of human decidua-associated lymphoid cells in normal early pregnancy. J. Immunol. 152:1994;2020-2032.
38. Liu W.J., Gottshall S.L., Hansen P.J. Increased expression of cell surface markers on endometrial γδ T cell receptor intraepithelial lymphocytes induced by the local presence of the sheep conceptus. Am. J. Reprod. Immunol. 37:1997;199-205.
39. Kimura M., Hanawa H., Watanabe H., Ogawa M., Abo T. Synchronous expansion of intermediate TCR cells in the liver and uterus during pregnancy. Cell. Immunol. 162:1995;15-25.
40. Meeusen E., Fox A., Brandon M., Lee C.S. Activation of uterine intraepithelial gamma delta T cell receptor positive lymphocytes during pregnancy. Eur. J. Immunol. 23:1993;1112-1117.
41. Mincheva Nilsson L., Kling M., Hammartstrom S., Nagaeva O., Sundkvist K.-G., Hammarstrom M.-L.et al. γ/δ T cells of human early pregnancy decidua. J. Immunol. 159:1997;3266-3277.
42. Kovats S., Main E.K., Librach C., Stubbelbine M., Fisher S.J., Demars R. A class I antigen HLA-G is expressed on human trophoblast. Science. 248:1990;220-223.
43. Hedley M.L., Drake B.L., Head J.R., Tucker W., Forman J. Differential expression of class I MHC genes in the embryo and placenta during mid-gestational development in the mouse. J. Immunol. 142:1989;4046-4053.
44. Hammer A., Hutter H., Dohr G. HLA class I expression on the materno-fetal interface. Am. J. Reprod. Immunol. 38:1997;150-157.
45. Le Bouteiller P., Rodriguez A.M., Mallet V., Girr M., Guillaudeux T., Lnefant F. Placental expression of HLA class I genes. Am. J. Reprod. Immunol. 35:1996;216-225.
46. van Kaer L., Wu M., Ichikawa Y.et al. Recognition of MHC TL gene products by γδ T cells. Immunol. Rev. 120:1991;89-115.
47. Heyborne K., Yang-Xin Fu., Nelson A., Farr A., O'Brien R., Born W. Recognition of trophoblasts by γ/δ T cells. J. Immunol. 153:1994;2918-2926.
48. Groh V., Porcelli S., Fabbi M., Lanier I.L., Picker L.J., Anderson T.et al. Human lymphocytes bearing T cells receptor γδ are phenotypically diverse and evenly distributed throughout the lymphoid system. J. Exp. Med. 169:1989;1277-1294.
49. Parker C.M., Groh V., Band H., Porcelli S.A., Morita C., Fabbi M.et al. Evidence for extra-thymic changes in the T cell receptor gamma/delta repertoir. J. Exp. Med. 171:1990;1597-1612.
50. Brenner M.B., McLean J., Scheft H., Riberdy J., AnG S.L., Seidman G.et al. Two forms of the T cell receptor gamma delta protein found on peripheral blood cytotoxic T lymphocytes. Nature. 325:1987;689-694.
51. Burk M.R., Mori L., de Libero G. Human Vγ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 25:1995;2052-2058.
52. Bukowski J.F., Morita C.T., Tanaka Y., Bloom B.R., Brenner M.B., Band H. Vγ2Vδ2 TCR dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J. Immunol. 154:1995;998-1006.
53. Yamamoto K. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19:1985;209-252.
54. DiRosa M., Persico P. Mechanism of inhibiton of prostaglandin biosynthesis by hydrocortisone n rat leucocytes. Br. J. Pharmacol. 66:1979;161-163.
55. Hirata F., Schiffman E., Ventakasubramanian K., Salomon D., Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Natl. Acad. Sci. U. S. A. 77:1980;5233-5236.
56. Blackwell G.J., Carnuccio R., DiRosa M., Flower R., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 287:1980;147-149.
57. Szekeres-Bartho J., Kilar F., Faljay G., Csernus V., Torok A., Pacsa A.S. Progesterone-treated lymphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis. Am. J. Reprod. Immunol. Microbiol. 9:1985;15-18.
58. Par G., Bartok B., Szekeres-Bartho J. Cyclooxygenase is involved in the effect of Progesterone Induced Blocking Factor (PIBF) on IL-12 production. Am. J. Obstet. Gynecol. 183:2000;126-130.
59. Szekeres-Bartho J., Autran B., Debre P., Andreu G., Denver L., Chaouat G. Immunoregulatory effects of a suppressor factor from healthy pregnant womens lymphocytes after progesterone induction. Cell. Immunol. 122:1989;281-294.
60. Szekeres-Bartho J., Wegmann T.G., Kelemen K., Bognar I., Fausts Zs., Varga P. Interaction of progesterone- and cytokine-mediated immunomodulatory mechanisms in favor of successful gestation. Reg. Immunol. 6:1995;315-319.
61. Szekeres-Bartho J., Wegmann T.G. A progesterne-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 31:1996;81-95.
62. Szekeres-Bartho J., Kinsky R., Chaouat G. The effect of a progesterone induced immunologic blocking factor on NK-mediated resorption. Am. J. Reprod. Immunol. 24:1990;105-107.
63. Szekeres-Bartho J., Chaouat G. Lymphocyte-derived progesterone induced blocking factor corrects resorption in a murine abortion system. Am. J. Reprod. Immunol. 23:1990;26-28.
64. Szekeres-Bartho J., Kinsky R., Chaouat G. A progesterone-induced immunologic blocking factor corrects high resorption rate in mice treated with anti-progesterone. Am. J. Obstet. Gynecol. 163:1990;1320-1322.
65. Szekeres-Bartho J., Par G., Dombay Gy., Smart Y.C., Volgyi Z. The anti-abortive effect of PIBF in mice is manifested by modulating NK activity. Cell. Immunol. 177:1997;194-199.
66. Szekeres-Bartho J., Par G., Szereday L., Smart C.Y., Achacz I. Progesterone and non-specific immunological mechanisms in pregnancy. Am. J. Reprod. Immunol. 38:1997;176-182.
67. Daya S., Clark D.A. Immunosuppressive factor (or factors) produced by human embryos in vitro. N. Engl. J. Med. 24:1986;1551-1552.
68. Kelemen K., Paldi A., Tinneberg H., Torok A., Szekeres-Bartho J. Early recognition of pregnancy by the maternal immune system. Am. J. Reprod. Immunol. 39:1998;351-355.
69. Shiu H.M., Schottenfeld D., McLean B., Fortner J.G. Adverse effect of pregnancy on melanoma. Cancer. 37:1976;181-187.
70. Lichtenstein M.R. Tuberculin reaction in tuberculosis during pregnancy. Am. Rev. Tuberc. Pulm. Dis. 48:1942;89-93.
71. Dresser D.E. The potentiating effect of pregnancy on humoral immune responses of mice. J. Reprod. Immunol. 20:1991;253-256.
72. Myers M.J., Petersen B.H. Estradiol induced alterations of the immune system: I. Enhancement of IgM production. Int. J. Immunopharmacol. 7:1985;207-213.
73. Santoli D., Trinchieri G., Zmijewsky C.M., Koprowsky H. HLA-related control of spontaneous and antibody-dependence-mediated cytotoxic activity in humans. J. Immunol. 117:1976;765-770.
74. Pickard R.E. Varicella pneumonia in pregnancy. Am. J. Obstet. Gynecol. 100:1968;504-506.
75. Gleicher N., Cohen C.J., Deppe G. Familial malignant melanoma of the female genitalia. Obstet. Gynecol. Surv. 34:1979;1-15.
76. Wegmann T.G., Huiin L., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today. 14:1993;353-356.
77. Tangri S., Wegmann T.G., Lin H., Raghupathy R. Maternal anti-placental reactivity in natural immunologically-mediated fetal resorptions. J. Immunol. 152:1994;4903-4911.
78. Chaouat G., Menu E., Kinsky R., Dy M., Minkowsky M., Delage G.et al. Lymphokines and non specific cellular lytic effectors at the feto-maternal site affect fetal size and survival. Metter L. Reproductive Immunology. 1989;283-289 Elsevier, Amsterdam.
79. Parant M. Possible mediators of endotoxin-induced abortions. Res. Immunol. 141:1990;164-168.
80. Wang Y., Campbell H.D., Young I.G. Sex hormones and dexamethasone modulate interleukin-5 gene expression in T lymphocytes. J. Steroid Biochem. Mol. Biol. 44:1993;203-210.
81. Wegmann T.G., Waters C.A., Drell D.W., Carlrson G.A. Pregnant mice are not primed but can be primed to fetal alloantigens. Proc. Natl. Acad. U. S. A. 76:1979;2410-2414.
82. Kuhn R., Rajewsky K., Muller W. IL-4 and IL-10 deficient mice. 8th Int. Congress of Immunology. 203:1992;. (Abstr.).
83. Gendron R., Baines M. Infiltrating decidual natural killer cells are associated with spontaneous abortions in mice. Cell. Immunol. 113:1988;261-268.
84. De Fougerolles R., Baines M. Modulation of natural killer activity influences resorption rates in CBA×DBA/2 matings. J. Reprod. Immunol. 11:1987;147-153.
85. Aoki K., Kajiura S., Matsumoto Y., Ogasawara M., Okada S., Yagami Y.et al. Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet. 345:1995;1340-1342.
86. Szekeres-Bartho J., Csernus V., Hadnagy J., Pacsa A.S. Immunosuppressive effect of progesterone during pregnancy depends on the progesterone binding capacity of the lymphocytes. J. Reprod. Immunol. 5:1983;81-88.
87. Szekeres-Bartho J., Varga P., Pacsa A.S. Immunological factors contributing to the initiation of labour-lymphocyte reactivity in term labour and threatened pre-term delivery. Am. J. Obstet. Gynecol. 155:1986;108-112.
88. Starkey P.M., Sargent L.L., Redman C.W.G. Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology. 65:1988;129-134.
89. Croy B.A., Gambel P., Rossant J., Wegmann T.G. Characterization of murine decidual natural killer (NK) cells and their relevance to the success of pregnancy. Cell. Immunol. 93:1985;315-326.
90. Croy B.A., Waterfield A., Wood W., King G.J. Normal murine and porcine embryos recruit NK cells to the uterus. Cell. Immunol. 115:1988;471-480.
91. Chao K.-H., Yang Y.-S., Ho H.-N., Chen S.-U., Chen H.-F., Dai H.J.et al. Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion. Am. J. Reprod. Immunol. 34:1995;274-280.
92. Szekeres-Bartho J., Faust Zs., Varga P., Szereday L., Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am. J. Reprod. Immunol. 35:1996;348-351.
93. Szereday L., Varga P., Szerkeres-Bartho J. Cytokine production in pregnancy. Am. J. Reprod. Immunol. 38:1997;418-422.
94. Faust Zs., Laskarin G., Rukavina D., Szekeres-Bartho J. Progesterone induced blocking factor inhibits degranulation of NK cells. Am. J. Reprod. Immunol. 42:1999;71-75.
95. Ferry B.L., Starkey P.M., Sargent I.L., Watt G.M., Jackson M., Redman C.W. Cell populations in the human early pregnancy decidua: natural killer activity and response tointerleukin-2 of CD56-positive large granular lymphocytes. Immunology. 70:1990;446-452.
96. Parhar R.S., Yagel S., Lala P.K. PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leucocytes in the decidua with potential anti-trophoblast activity. Cell. Immunol. 120:1989;61-74.
97. Strassmann G., Patil-Koota V., Finkelman F., Fong M., Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180:1994;2365-2370.
98. van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:1995;775-779.
99. Wu C.Y., Wang K., McDyer J.F., Seder R.A. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161:1998;2723-2730.
100. Visser J., van-Boxel-Dezaire A., Methorst D., Brunt T., de-Kloet E.R., Nagelkerken L. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood. 91(11):1998;4255-4264.
101. Snijdewint F.G.M., Kalinski P., Wierenga E.A., Bos J.D., Kapsenberg M.L. Prostaglandin E2 differently modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:1993;5321-5328.
102. Kikuchi Y., Hirata J., Kuki E., Nagata I., Fukushima M. Modulation of human lymphocyte resonse to phytochemagglutinin by antineoplastic prostaglandins. Int. J. Immunopharmacol. 14(1):1992;105-110.
103. Skinner M., Skinner S., Marbrook J. The effect of prostaglandins and indomethacine on cytotoxic T-lymphocytes and their percursors. Int. J. Immonopharmacol. 11(3):1989;267-273.
104. Hilkens C.M., Vermeulen H., van-Neerven R.J., Snijdewint F.G., Wierenga E.A., Kapsenberg M.L. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25(1):1995;59-63.
105. Ching C.Y., Ching N., Seto D.S., Hokama Y. Relationships of prostaglandin levels and natural killer (NK) cell cytotoxity of mononuclear cells in cord blood. J. Med. 15(3):1984;233-236.
106. Croz B.A., Chantakru S., Narumiya S., Ichikawa A., Sugimoto Y. Prolonged gestation does not extend survival of uterine natural killer lymphocytes in mice deleted in the receptor for prostaglandin F2alpha. J. Reprod. Immunol. 46(2):2000;125-129.
107. Ishihara O., Matsuoka K., Kinoshita K., Sullivan M.H., Elder M.G. Interleukin-1 beta-stimulated PGE2 production from early first trimester human decidual cells is inhibited by dexamethasone and progesterone. Prostaglandins. 49(1):1995;15-26.
108. Szekeres-Bartho J., Varga P., Pacsa A.S. Immunological factors contributing to the initiation of labour-lymphocyte reactivity in term labour and threatened pre-term delivery. Am. J. Obstet. Gynecol. 155:1986;108-112.
109. Smith S.K., Kelly R.W. The release of PF2a and PGE2 from separated cells of human endometrium and decidua. Prostaglandins, Leukotrienes Essent. Fatty Acids. 33:1988;91-96.
110. Dudley D.J., Chen C.L., Branch D.W., Hammond E., Mitchell M.D. A murine model of pattern labor: inflammatory mediators regulate the production of prostaglandin E2 and interleukin-6 by murine decidua. Biol. Reprod. 48:1993;33-39.
111. Gendron R.L., Farookhi R., Baines M.G. Murine pregnancies predisposed to spontaneous resorption show alterations in the concentration of leukotriene B4 and prostaglandn E2. Biol. Reprod. 47:1992;72-75.
112. Szekeres-Bartho J., Csernus V., Hadnagy J., Pacsa A.S. Effect of long-term treatment with acetylsalicylic acid and 17-hydroxyprogesterone caproate on cytotoxic acitivity and progesterone binding capacity of lymphocytes from pregnant women. Prostaglandins. 26:1983;187-192.
113. Lewis R.B., Schulam J.D. Influence of acetylsalicylic acid: an inhibitor of prostaglandin synthesis on the duration of human gestation and labour. Lancet. 2:1973;1159-1161.
114. Check J., Szekeres-Bartho J., O'Slaughnessy A. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation. Am. J. Reprod. Immunol. 35:1996;277-280.
115. Szekeres-Bartho J., Faust Zs., Varga P. Progesterone-induced blocking factor (PIBF) in normal and pathological pregnancy. Am. J. Reprod. Immunol. 34:1995;342-348.